Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-113897
Filing Date
2024-11-04
Accepted
2024-11-04 16:15:57
Documents
17
Effectiveness Date
2024-11-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2427253d1_s8.htm S-8 44241
2 EXHIBIT 5.1 tm2427253d1_ex5-1.htm EX-5.1 13948
3 EXHIBIT 23.1 tm2427253d1_ex23-1.htm EX-23.1 2254
4 EX-FILING FEES tm2427253d1_ex-filingfees.htm   iXBRL EX-FILING FEES 15101
5 GRAPHIC tm2427253d1_ex5-1img001.jpg GRAPHIC 9723
6 GRAPHIC tm2427253d1_ex5-1img002.jpg GRAPHIC 7864
  Complete submission text file 0001104659-24-113897.txt   228404

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2427253d1_ex-filingfees_htm.xml XML 5613
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282981 | Film No.: 241423764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)